Subscribe: Food and Drug Administration--Press Releases
http://www.fda.gov/bbs/topics/news/rssPress.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
commissioner scott  commissioner  fda commissioner  fda  gottlieb  new  products  scott gottlieb  scott  statement fda  statement 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Food and Drug Administration--Press Releases

Food and Drug Administration--Press Releases



Press releases from FDA



Last Build Date: Fri, 16 Feb 2018 16:48:00 -0500

 



FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing

Fri, 16 Feb 2018 16:48:00 -0500

FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing



Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine

Thu, 15 Feb 2018 16:20:00 -0500

FDA provides update on flu vaccines during this severe flu season



FDA expands treatment window for use of clot retrieval devices in certain stroke patients

Thu, 15 Feb 2018 12:20:00 -0500

FDA expands treatment window for use of clot retrieval devices in certain stroke patient



Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs

Thu, 15 Feb 2018 09:31:00 -0500

FDA’s 5 guidance documents provide details for drug development for neurological conditions such as ALS and Alzheimer’s disease



FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

Wed, 14 Feb 2018 13:46:00 -0500

FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer



FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

Wed, 14 Feb 2018 13:21:00 -0500

FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults; new quick testing option to help reduce need for CT scans, radiation exposure for patients



FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

Tue, 13 Feb 2018 15:58:00 -0500

FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients



Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition

Tue, 13 Feb 2018 15:33:00 -0500

Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition



Statement from FDA Commissioner Scott Gottlieb, M.D., on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.

Thu, 08 Feb 2018 11:43:00 -0500

FDA announces on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.



FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

Thu, 08 Feb 2018 11:26:00 -0500

FDA and NRC today took important steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases



Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse

Tue, 06 Feb 2018 14:06:00 -0500

FDA statement on scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse



Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure

Fri, 02 Feb 2018 13:11:00 -0500

One part of the Food and Drug Administration’s mission is to ensure the safety of electronic products that emit radiation, like televisions and cell phones. These types of products are part of Americans’ daily life and we take our duty to protect consumers with the utmost gravity. With cell phones, we have relied extensively on a myriad scientific evidence developed over many years to help inform our regulatory thinking. Although the Federal Communications Commission (FCC) sets the standard for radiofrequency energy exposure limits from cell phones, the FCC relies on the FDA and other health agencies for scientific expertise and input regarding those standards.



Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to mitigate impact of saline shortages during this flu season

Thu, 01 Feb 2018 15:18:00 -0500

FDA provides update on ongoing efforts to mitigate impact of saline shortages and monitor other critical products during flu season



Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help prevent new addiction, curb abuse and overdose related to opioid products

Tue, 30 Jan 2018 10:34:00 -0500

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help prevent new addiction, curb abuse and overdose related to opioid products



FDA, USDA announce formal agreement to bolster coordination and collaboration

Tue, 30 Jan 2018 09:38:00 -0500

FDA Commissioner Dr. Scott Gottlieb and USDA Secretary Perdue launched an effort today to increase collaboration, efficiency and effectiveness, and provide clarity to food producers.



FDA approves new treatment for certain digestive tract cancers

Fri, 26 Jan 2018 11:55:00 -0500

FDA approves first radioactive drug for a certain type of digestive tract cancer called GEP-NETs



Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s strengthened commitments to humane and judicious animal research and the termination of a nicotine study

Fri, 26 Jan 2018 10:21:00 -0500

FDA strengthens commitments to humane and judicious animal research and the termination of a nicotine study



FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims

Wed, 24 Jan 2018 10:28:00 -0500

FDA and FTC issued joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal



Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy steps for strengthening public warning and notification of recalls

Thu, 18 Jan 2018 15:16:00 -0500

FDA discusses new policy steps for strengthening public warning and notification of recalls



Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review

Tue, 16 Jan 2018 14:36:00 -0500

Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review